Overview

Telmisartan Effectiveness on Left Ventricular Mass Reduction (TELMAR) as Assessed by MRI, in Patients With Mild to Moderate Hypertension

Status:
Terminated

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

The primary objective was to show that telmisartan is not inferior to metoprolol succinate in respect of the percentage change from baseline in LVMI(H) after a 6.5 months treatment period. As secondary objectives, the improvement in left ventricular systolic and diastolic function and blood pressure reduction were assessed

Phase:

Phase 4

Details

Lead Sponsor:

Boehringer Ingelheim

Treatments:

Metoprolol
Telmisartan